ChoA Pharmaceutical Co.Ltd (034940) — Cash Flow Reinvestment Rate
ChoA Pharmaceutical Co.Ltd (034940) has a Cash Flow Reinvestment Rate of 2.22x as of September 2025, reinvesting ₩2.80 Billion (capex ₩324.67 Million plus investments ₩-2.48 Billion) from operating cash flow of ₩1.26 Billion. Check 034940 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ChoA Pharmaceutical Co.Ltd Cash Flow Reinvestment Rate (2004–2020)
Historical reinvestment intensity for ChoA Pharmaceutical Co.Ltd across 8 annual periods. Explore long-term investment intensity of ChoA Pharmaceutical Co.Ltd to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for ChoA Pharmaceutical Co.Ltd (2004–2020)
Year-by-year capital reinvestment analysis for ChoA Pharmaceutical Co.Ltd. For live market cap and broader valuation context, see 034940 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 1.89x | ₩3.63 Billion | ₩1.92 Billion | ₩3.60 Billion | ▲ +248.0% |
| 2019 | 0.54x | ₩2.25 Billion | ₩4.16 Billion | ₩1.39 Billion | ▼ -62.6% |
| 2018 | 1.45x | ₩2.96 Billion | ₩2.04 Billion | ₩1.97 Billion | ▼ -56.1% |
| 2016 | 3.30x | ₩3.07 Billion | ₩930.42 Million | ₩2.30 Billion | ▲ +26.5% |
| 2015 | 2.61x | ₩3.10 Billion | ₩1.19 Billion | ₩1.78 Billion | ▼ -72.7% |
| 2014 | 9.55x | ₩5.97 Billion | ₩625.52 Million | ₩5.64 Billion | ▲ +3059.9% |
| 2013 | 0.30x | ₩1.07 Billion | ₩3.53 Billion | ₩1.07 Billion | ▲ +110.8% |
| 2004 | 0.14x | ₩512.47 Million | ₩3.57 Billion | ₩512.47 Million | — |